Rare diseases
Investigational molecules
Locations
Nyiri Ut 38, 6000 Kecskemet, Hungary
Bacs-Kiskun Varmegyei Oktatokorhaz in Kecskemet, Hungary specialises in clinical trials of conditions such as Non-small cell lung cancer, Non-small cell lung cancer stage IV, Non-small cell lung cancer metastatic, Breast cancer, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in Microsatellite Instability-High (MSI-H) and Mismatch Repair Deficient (dMMR) colorectal cancer, focusing on innovative therapies to improve patient outcomes.
Through rigorous clinical trials, the center is advancing the understanding of treatment efficacy in metastatic colorectal cancer.
Specializing in clear cell renal cell carcinoma (ccRCC), the center is pioneering research in first-line treatment options, combining immune and targeted therapies to enhance survival rates.
These studies are crucial in developing more effective treatment protocols for advanced renal cancer.
Research at the center includes extensive work on extensive-stage small-cell lung cancer (ES-SCLC), focusing on novel drug combinations to improve overall survival.
These efforts are pivotal in offering new hope for patients with aggressive lung cancer types.
The center is a leader in breast cancer research, particularly in hormone receptor-positive and triple-negative breast cancer (TNBC), exploring cutting-edge therapies to improve patient outcomes.
These studies are instrumental in developing personalized treatment plans for breast cancer patients.
Focusing on adjuvant treatment for hepatocellular carcinoma, the center is conducting pivotal trials to assess the efficacy of immunotherapy in preventing cancer recurrence.
This research is vital in improving long-term outcomes for liver cancer patients post-surgery.
The center is advancing research in muscle invasive bladder cancer, focusing on the integration of immunotherapy with chemoradiation to enhance treatment efficacy.
These trials are crucial in developing more effective treatment strategies for bladder cancer patients.
Research at the center includes groundbreaking studies on non-small cell lung cancer (NSCLC), focusing on novel drug combinations to improve survival rates.
These efforts are pivotal in offering new hope for patients with advanced lung cancer.
The center is at the forefront of research in metastatic castration-resistant prostate cancer (mCRPC), exploring the efficacy of novel drug combinations to improve patient outcomes.
These studies are crucial in developing more effective treatment protocols for advanced prostate cancer.
Specializing in lipoprotein disorders, the center is pioneering research to evaluate the efficacy and safety of novel treatments for patients at high risk for cardiovascular events.
This research is vital in improving cardiovascular health and preventing adverse events.
The center is leading research in alopecia areata, focusing on the efficacy and safety of novel treatments to manage this autoimmune condition.
These efforts are crucial in developing effective therapies for patients with severe alopecia areata.
Clinical trials currently enrolling participants at this site.
HungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
